Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies”
Format: | Article |
---|---|
Language: | English |
Published: |
SAGE Publishing
2024-03-01
|
Series: | Cephalalgia Reports |
Online Access: | https://doi.org/10.1177/25158163241233831 |
ISSN: | 2515-8163 |
---|